AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioLineRx Ltd.

Proxy Solicitation & Information Statement Aug 20, 2024

6692_rns_2024-08-19_f2c99c7c-1cf6-4b83-be4b-a3fde49dfb11.pdf

Proxy Solicitation & Information Statement

Open in Viewer

Opens in native device viewer

Exhibit 99.2

BIOLINERX LTD.

For the Annual General Meeting of Shareholders to be held on October 1, 2024

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

The undersigned shareholder of BioLineRx Ltd. (the "Company") hereby appoints Netanel Derovan and/or Raziel Fried, and each or either of them, the true and lawful attorney, agent and proxy of the undersigned, with full power of substitution, to vote, as designated on the reverse side, all of the ordinary shares of the Company which the undersigned is entitled in any capacity to vote at the Annual General Meeting of Shareholders of the Company which will be held at the offices of the Company at Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in 7177871, Israel, on October 1, 2024 at 3:00 p.m. (Israel time) (the "Meeting"), and all adjournments and postponements thereof.

(CONTINUED AND TO BE SIGNED ON REVERSE SIDE)

SEE REVERSE SIDE

ANNUAL GENERAL MEETING OF SHAREHOLDERS OF

BIOLINERX LTD.

October 1, 2024

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED HEREIN.
IF NO DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED "FOR" THE ELECTION OF
THE DIRECTORS NAMED IN ITEM 1 AND "FOR" ALL OTHER PROPOSALS.
Please mark your vote for the following resolutions as in this example ☒
1 TO APPROVE the re-election of the following persons as Class I directors, each to serve until the Company's annual
general meeting of shareholders to be held in 2027, and until their respective successors have been duly elected and
qualified.
FOR AGAINST ABSTAIN
Dr. Avraham Molcho
Mr. Gal Cohen
Mr. Rami Dar
2. TO APPROVE the grant of options to purchase American Depositary Shares, each representing 15 ordinary shares of the
Company, to certain directors of the Company who shall serve in such capacity immediately following the Meeting.
FOR
AGAINST
ABSTAIN
3. TO APPROVE an increase in the Company's authorized share capital, and to amend the Company's Articles of
Association accordingly.
FOR
AGAINST
ABSTAIN
4. TO APPROVE the reappointment of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of
PricewaterhouseCoopers International Limited, as the Company's independent registered public accounting firm for the
year ending December 31, 2024, and until the Company's next annual general meeting of shareholders, and to authorize
the Audit Committee of the Board of Directors to fix the compensation of said auditors in accordance with the scope and
nature of their services.
FOR
AGAINST
ABSTAIN
Name:
Number of shares:
Signature:
Date:
NOTE: Please mark date and sign exactly as the name(s) appear on this proxy. If the signer is a corporation, please sign the full corporate name by a duly authorized officer. Executors,
administrators, trustees, etc. should state their full title or capacity. Joint owners should each sign.

Talk to a Data Expert

Have a question? We'll get back to you promptly.